Halofantrine
- TRADE NAME: Halfan (GSK)
- INDICATIONS: Malaria
- CLASS: Antimalarial
- HALF-LIFE: 6–10 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aprepitant, Artemether/Lumefantrine, Chloroquine, Conivaptan, Darunavir, Delavirdine, Efavirenz, Indinavir, Itraconazole, Ketoconazole, Mefloquine, Nilotinib, Quinine, Ribociclib, Sulpiride, Telithromycin, Voriconazole
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
